1 Min Read
Sept 27 (Reuters) - Cadila Healthcare Ltd:
* Zydus gets final approval from U.S.FDA for Indomethacin Extended-release capsules USP used for treating inflammatory conditions Source text: bit.ly/2fxrHCm Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.